Autonomix Medical to Showcase Long-Term Pain Mitigation Results in Pancreatic Cancer at SIR 2026
ByAinvest
Wednesday, Apr 8, 2026 8:41 am ET1min read
AMIX--
Autonomix Medical's abstract on long-term pain mitigation in pancreatic cancer has been selected for a Featured Abstract presentation at the Society of Interventional Radiology 2026 Annual Scientific Meeting. The study evaluates the effectiveness of denervation using transvascular radiofrequency energy-based ablation in patients with pancreatic adenocarcinoma. The presentation will be delivered by Dr. Lindsay Machan on April 12. The abstract highlights the importance of addressing cancer-related pain and the potential of Autonomix's technology to offer a new therapeutic option for pain management.

Stay ahead of the market.
Get curated U.S. market news, insights and key dates delivered to your inbox.
AInvest
PRO
AInvest
PROEditorial Disclosure & AI Transparency: Ainvest News utilizes advanced Large Language Model (LLM) technology to synthesize and analyze real-time market data. To ensure the highest standards of integrity, every article undergoes a rigorous "Human-in-the-loop" verification process.
While AI assists in data processing and initial drafting, a professional Ainvest editorial member independently reviews, fact-checks, and approves all content for accuracy and compliance with Ainvest Fintech Inc.’s editorial standards. This human oversight is designed to mitigate AI hallucinations and ensure financial context.
Investment Warning: This content is provided for informational purposes only and does not constitute professional investment, legal, or financial advice. Markets involve inherent risks. Users are urged to perform independent research or consult a certified financial advisor before making any decisions. Ainvest Fintech Inc. disclaims all liability for actions taken based on this information. Found an error?Report an Issue



Comments
No comments yet